IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity

Myung Shik Lee, Regula Mueller, Linda S. Wicker, Laurence B. Peterson, Nora E Sarvetnick

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Contrary to expectations based on in vitro experiments, we previously found that pancreatic IL-10 did not inhibit autoimmune diabetes but accelerated it in an MHC-dependent manner. Therefore, the ability of IL-10 to overcome the absence of all non-MHC diabetes susceptibility (Idd) alleles was studied in transgenic mice expressing pancreatic IL-10 backcrossed to B10.H2(g7) congenic mice, which have no Idd alleles other than NOD MHC (H2(g7)). IL-10 transgenic backcross 1 (BC1) mice with H2(g7/g7) haplotype developed clear-cut insulitis and diabetes, but neither transgenic mice with the H2(g/b) haplotype nor nontransgenic BCL mice did so. Further implicating IL-10 in autoimmune diabetes, anti-IL-10 antibody treatment inhibited the development of insulitis in NOD mice. These results suggest that IL-10 may be necessary and sufficient for producing autoimmune diabetes in conjunction with NOD MHC homozygosity and that some Idd genes may be related to the regulation of IL-10.

Original languageEnglish (US)
Pages (from-to)2663-2668
Number of pages6
JournalJournal of Experimental Medicine
Volume183
Issue number6
DOIs
StatePublished - Jun 1 1996

Fingerprint

Type 1 Diabetes Mellitus
Interleukin-10
Haplotypes
Transgenic Mice
Alleles
Congenic Mice
Inbred NOD Mouse
Antibodies
Genes

ASJC Scopus subject areas

  • Immunology

Cite this

IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. / Lee, Myung Shik; Mueller, Regula; Wicker, Linda S.; Peterson, Laurence B.; Sarvetnick, Nora E.

In: Journal of Experimental Medicine, Vol. 183, No. 6, 01.06.1996, p. 2663-2668.

Research output: Contribution to journalArticle

Lee, Myung Shik ; Mueller, Regula ; Wicker, Linda S. ; Peterson, Laurence B. ; Sarvetnick, Nora E. / IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. In: Journal of Experimental Medicine. 1996 ; Vol. 183, No. 6. pp. 2663-2668.
@article{b9d9ff9d06744c628ef4ecfa764d536d,
title = "IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity",
abstract = "Contrary to expectations based on in vitro experiments, we previously found that pancreatic IL-10 did not inhibit autoimmune diabetes but accelerated it in an MHC-dependent manner. Therefore, the ability of IL-10 to overcome the absence of all non-MHC diabetes susceptibility (Idd) alleles was studied in transgenic mice expressing pancreatic IL-10 backcrossed to B10.H2(g7) congenic mice, which have no Idd alleles other than NOD MHC (H2(g7)). IL-10 transgenic backcross 1 (BC1) mice with H2(g7/g7) haplotype developed clear-cut insulitis and diabetes, but neither transgenic mice with the H2(g/b) haplotype nor nontransgenic BCL mice did so. Further implicating IL-10 in autoimmune diabetes, anti-IL-10 antibody treatment inhibited the development of insulitis in NOD mice. These results suggest that IL-10 may be necessary and sufficient for producing autoimmune diabetes in conjunction with NOD MHC homozygosity and that some Idd genes may be related to the regulation of IL-10.",
author = "Lee, {Myung Shik} and Regula Mueller and Wicker, {Linda S.} and Peterson, {Laurence B.} and Sarvetnick, {Nora E}",
year = "1996",
month = "6",
day = "1",
doi = "10.1084/jem.183.6.2663",
language = "English (US)",
volume = "183",
pages = "2663--2668",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "6",

}

TY - JOUR

T1 - IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity

AU - Lee, Myung Shik

AU - Mueller, Regula

AU - Wicker, Linda S.

AU - Peterson, Laurence B.

AU - Sarvetnick, Nora E

PY - 1996/6/1

Y1 - 1996/6/1

N2 - Contrary to expectations based on in vitro experiments, we previously found that pancreatic IL-10 did not inhibit autoimmune diabetes but accelerated it in an MHC-dependent manner. Therefore, the ability of IL-10 to overcome the absence of all non-MHC diabetes susceptibility (Idd) alleles was studied in transgenic mice expressing pancreatic IL-10 backcrossed to B10.H2(g7) congenic mice, which have no Idd alleles other than NOD MHC (H2(g7)). IL-10 transgenic backcross 1 (BC1) mice with H2(g7/g7) haplotype developed clear-cut insulitis and diabetes, but neither transgenic mice with the H2(g/b) haplotype nor nontransgenic BCL mice did so. Further implicating IL-10 in autoimmune diabetes, anti-IL-10 antibody treatment inhibited the development of insulitis in NOD mice. These results suggest that IL-10 may be necessary and sufficient for producing autoimmune diabetes in conjunction with NOD MHC homozygosity and that some Idd genes may be related to the regulation of IL-10.

AB - Contrary to expectations based on in vitro experiments, we previously found that pancreatic IL-10 did not inhibit autoimmune diabetes but accelerated it in an MHC-dependent manner. Therefore, the ability of IL-10 to overcome the absence of all non-MHC diabetes susceptibility (Idd) alleles was studied in transgenic mice expressing pancreatic IL-10 backcrossed to B10.H2(g7) congenic mice, which have no Idd alleles other than NOD MHC (H2(g7)). IL-10 transgenic backcross 1 (BC1) mice with H2(g7/g7) haplotype developed clear-cut insulitis and diabetes, but neither transgenic mice with the H2(g/b) haplotype nor nontransgenic BCL mice did so. Further implicating IL-10 in autoimmune diabetes, anti-IL-10 antibody treatment inhibited the development of insulitis in NOD mice. These results suggest that IL-10 may be necessary and sufficient for producing autoimmune diabetes in conjunction with NOD MHC homozygosity and that some Idd genes may be related to the regulation of IL-10.

UR - http://www.scopus.com/inward/record.url?scp=0029896602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029896602&partnerID=8YFLogxK

U2 - 10.1084/jem.183.6.2663

DO - 10.1084/jem.183.6.2663

M3 - Article

VL - 183

SP - 2663

EP - 2668

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 6

ER -